Device Developer Hit with Second Warning Letter in 18 Months

Devices & Diagnostics Letter
KEYWORDS FDA / Warning
A A

Fertility device developer Medelle of Woburn, Mass., failed to investigate adverse events, the FDA said in a warning letter. The agency also cited the firm for failing to turn records over to an FDA investigator.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00